サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1672056

マイクロバイオームシーケンスサービスの世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）

Global Microbiome Sequencing Services Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 330 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
マイクロバイオームシーケンスサービスの世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 330 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のマイクロバイオームシーケンスサービスの市場規模は、2024年の26億2,000万米ドルから2033年には132億5,000万米ドルに成長し、2026年～2033年の予測期間中に19.72％の堅調なCAGRを示すと予測されています。

マイクロバイオームシーケンスサービス市場は、健康と疾患におけるヒトマイクロバイオームの役割に対する認識の高まりに後押しされ、大きく成長する見通しです。微生物群集とさまざまな健康状態との間の複雑な関係が研究によって明らかにされ続けているため、マイクロバイオームシーケンスサービスに対する需要が急増しています。これらのサービスにより、研究者や医療提供者は人体内の微生物集団の組成と機能を解析できるようになり、肥満、糖尿病、炎症性腸疾患などの疾患への影響に関する洞察が容易になります。次世代シーケンス（NGS）やメタゲノミクスなどのシーケンス技術の革新により、マイクロバイオーム解析の精度と効率が向上し、より幅広い用途に利用できるようになっています。

さらに、個別化医療の重視の高まりがマイクロバイオームシーケンスサービス市場に影響を与えています。医療提供者が個人のマイクロバイオームプロファイルに基づいて治療をオーダーメイドしようとする中、包括的なシーケンスサービスに対する需要が高まることが予想されます。この動向は、プロバイオティクスやマイクロバイオームベースの治療法の開発に特に関連しており、患者固有の微生物組成を理解することで、より効果的な介入を行うことができます。さらに、バイオインフォマティクスツールと機械学習アルゴリズムの統合によりデータ解析能力が強化され、マイクロバイオームの動態と健康への影響についてより深い洞察が可能になりつつあります。

さらに、予防医療とウェルネスへの関心の高まりがマイクロバイオーム研究への関心を高めています。消費者は腸内環境の重要性とその健康全般との関連性を認識するようになり、マイクロバイオーム検査サービスへの需要が急増しています。また、消費者直販の検査キットの台頭も、個人が自分のマイクロバイオーム・プロファイルを理解し、十分な情報を得た上でライフスタイルを選択しようとしていることから、市場の成長に寄与しています。まとめると、マイクロバイオームシーケンスサービス市場は、技術の進歩、個別化された健康への注目、人間の健康におけるマイクロバイオームの役割の理解強化へのコミットメントを特徴とし、堅調な拡大が見込まれています。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察をお客様に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます：

市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクションです。

市場力学：市場成長に影響を与える主な促進要因・抑制要因・機会・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに分けています。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場企業を包括的に評価しています。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：実績データと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測しています。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 マイクロバイオームシーケンスサービスの産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 マイクロバイオームシーケンスサービスの世界市場分析：技術別

  • 技術別の概要
  • 技術別の実績・予測データ分析
  • シーケンス

第6章 マイクロバイオームシーケンスサービスの世界市場分析：合成（SBS）別

  • 合成（SBS）別の概要
  • 合成（SBS）別の実績・予測データ分析
  • シーケンス

第7章 マイクロバイオームシーケンスサービスの世界市場分析：ライゲーション（SBL）別

  • ライゲーション（SBL）別の概要
  • ライゲーション（SBL）別の実績・予測データ分析
  • パイロシーケンス
  • サンガーシーケンス
  • その他

第8章 マイクロバイオームシーケンスサービスの世界市場分析：ラボタイプ別

  • ラボタイプ別の概要
  • ラボタイプ別の実績・予測データ分析
  • ドライラボ
  • ウェットラボ

第9章 マイクロバイオームシーケンスサービスの世界市場分析：研究タイプ別

  • 研究タイプ別の概要
  • 研究タイプ別の実績・予測データ分析
  • 外部委託研究
  • 内部研究

第10章 マイクロバイオームシーケンスサービスの世界市場分析：用途別

  • 用途別の概要
  • 用途別の実績・予測データ分析
  • ショットガンシーケンス
  • ターゲット遺伝子シーケンス
  • RNAシーケンス
  • 全ゲノムシーケンス
  • その他

第11章 マイクロバイオームシーケンスサービスの世界市場分析：エンドユーザー別

  • エンドユーザー別の概要
  • エンドユーザー別の実績・予測データ分析
  • 研究・学術機関
  • 製薬・バイオテクノロジー企業
  • その他

第12章 マイクロバイオームシーケンスサービスの世界市場分析：地域別

  • 地域別の展望
  • イントロダクション
  • 北米の売上分析
    • 概要・実績・予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要・実績・予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋の売上分析
    • 概要・実績・予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカの売上分析
    • 概要・実績・予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要・実績・予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第13章 マイクロバイオームシーケンスサービス企業の競合情勢

  • マイクロバイオームシーケンスサービス市場の競合
  • 提携・協力・協定
  • 合併・買収
  • 新製品の上市
  • その他の開発

第14章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Baseclear B.V.
  • Zymo Research Corporation
  • Second Genome
  • MR DNA（Molecular Research LP）
  • Microbiome Insights
  • MeRieux NutriSciences Corporation
  • Clinical-Microbiomics A/S
  • Rancho BioSciences
  • Diversigen
  • Molzym GmbH & Co. KG
  • BioSpherex LLC
  • Tgen
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Technology (Units and USD MN)
  • Sequencing Market Sales By Geography (Units and USD MN)
  • Analysis By Synthesis (SBS) (Units and USD MN)
  • Sequencing Market Sales By Geography (Units and USD MN)
  • Analysis By Ligation (SBL) (Units and USD MN)
  • Pyrosequencing Market Sales By Geography (Units and USD MN)
  • Sanger Sequencing Market Sales By Geography (Units and USD MN)
  • Others Market Sales By Geography (Units and USD MN)
  • ByLaboratory Type Market Sales By Geography (Units and USD MN)
  • Dry labs Market Sales By Geography (Units and USD MN)
  • Wet Labs Market Sales By Geography (Units and USD MN)
  • Analysis By Research Type (Units and USD MN)
  • Outsourced Research Market Sales By Geography (Units and USD MN)
  • Internal Research Market Sales By Geography (Units and USD MN)
  • ByApplication Market Sales By Geography (Units and USD MN)
  • Shotgun Sequencing Market Sales By Geography (Units and USD MN)
  • Targeted Gene Sequencing Market Sales By Geography (Units and USD MN)
  • RNA Sequencing Market Sales By Geography (Units and USD MN)
  • Whole Genome Sequencing Market Sales By Geography (Units and USD MN)
  • Other Market Sales By Geography (Units and USD MN)
  • ByEnd User Market Sales By Geography (Units and USD MN)
  • Research and Academic Institutes Market Sales By Geography (Units and USD MN)
  • Pharmaceutical and Biotechnology Companies Market Sales By Geography (Units and USD MN)
  • Others Market Sales By Geography (Units and USD MN)
  • Global Microbiome Sequencing Services Market Sales By Geography (Units and USD MN)
  • North America Market Analysis (Units and USD MN)
  • United States Market Analysis (Units and USD MN)
  • Canada Market Analysis (Units and USD MN)
  • Mexico Market Analysis (Units and USD MN)
  • Europe Market Analysis (Units and USD MN)
  • Europe Market Estimate By Country (Units and USD MN)
  • United Kingdom Market Analysis (Units and USD MN)
  • France Market Analysis (Units and USD MN)
  • Germany Market Analysis (Units and USD MN)
  • Italy Market Analysis (Units and USD MN)
  • Russia Market Analysis (Units and USD MN)
  • Spain Market Analysis (Units and USD MN)
  • Rest of Europe Market Analysis (Units and USD MN)
  • Asia Pacific Market Analysis (Units and USD MN)
  • China Market Analysis (Units and USD MN)
  • Japan Market Analysis (Units and USD MN)
  • India Market Analysis (Units and USD MN)
  • South Korea Market Analysis (Units and USD MN)
  • Australia Market Analysis (Units and USD MN)
  • South East Asia Market Analysis (Units and USD MN)
  • Rest of Asia Pacific Market Analysis (Units and USD MN)
  • Latin America Market Analysis (Units and USD MN)
  • Brazil Market Analysis (Units and USD MN)
  • Argentina Market Analysis (Units and USD MN)
  • Peru Market Analysis (Units and USD MN)
  • Chile Market Analysis (Units and USD MN)
  • Rest of Latin America Market Analysis (Units and USD MN)
  • Middle East & Africa Market Analysis (Units and USD MN)
  • Saudi Arabia Market Analysis (Units and USD MN)
  • UAE Market Analysis (Units and USD MN)
  • Israel Market Analysis (Units and USD MN)
  • South Africa Market Analysis (Units and USD MN)
  • Rest of Middle East and Africa Market Analysis (Units and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Microbiome Sequencing Services Report
  • Market Research Process
  • Market Research Methodology
  • Global Microbiome Sequencing Services Market Size, By Region (Units and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By Synthesis (SBS)
  • Market Attractiveness Analysis By Ligation (SBL)
  • Market Attractiveness Analysis By Research Type
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Technology (Units and USD MN)
  • Sequencing Market Sales By Geography (Units and USD MN)
  • Global Market Analysis By Synthesis (SBS) (Units and USD MN)
  • Sequencing Market Sales By Geography (Units and USD MN)
  • Global Market Analysis By Ligation (SBL) (Units and USD MN)
  • Pyrosequencing Market Sales By Geography (Units and USD MN)
  • Sanger Sequencing Market Sales By Geography (Units and USD MN)
  • Others Market Sales By Geography (Units and USD MN)
  • ByLaboratory Type Market Sales By Geography (Units and USD MN)
  • Dry labs Market Sales By Geography (Units and USD MN)
  • Wet Labs Market Sales By Geography (Units and USD MN)
  • Global Market Analysis By Research Type (Units and USD MN)
  • Outsourced Research Market Sales By Geography (Units and USD MN)
  • Internal Research Market Sales By Geography (Units and USD MN)
  • ByApplication Market Sales By Geography (Units and USD MN)
  • Shotgun Sequencing Market Sales By Geography (Units and USD MN)
  • Targeted Gene Sequencing Market Sales By Geography (Units and USD MN)
  • RNA Sequencing Market Sales By Geography (Units and USD MN)
  • Whole Genome Sequencing Market Sales By Geography (Units and USD MN)
  • Other Market Sales By Geography (Units and USD MN)
  • ByEnd User Market Sales By Geography (Units and USD MN)
  • Research and Academic Institutes Market Sales By Geography (Units and USD MN)
  • Pharmaceutical and Biotechnology Companies Market Sales By Geography (Units and USD MN)
  • Others Market Sales By Geography (Units and USD MN)
  • Global Market Sales (Units and USD MN)
  • North America Market Sales (Units and USD MN)
  • Europe Market Sales (Units and USD MN)
  • Asia Pacific Market Sales (Units and USD MN)
  • Latin America Market Sales (Units and USD MN)
  • Middle East & Africa Market Sales (Units and USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11219250

Global Microbiome Sequencing Services Market size is anticipated to grow from USD 2.62 Billion in 2024 to USD 13.25 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 19.72% during the forecast period of 2026 to 2033.

The microbiome sequencing services market is poised for significant growth, driven by the increasing recognition of the human microbiome's role in health and disease. As research continues to unveil the complex relationships between microbial communities and various health conditions, the demand for microbiome sequencing services is surging. These services enable researchers and healthcare providers to analyze the composition and function of microbial populations in the human body, facilitating insights into their impact on diseases such as obesity, diabetes, and inflammatory bowel disease. Innovations in sequencing technologies, including next-generation sequencing (NGS) and metagenomics, are enhancing the accuracy and efficiency of microbiome analysis, making it more accessible to a broader range of applications.

Moreover, the growing emphasis on personalized medicine is influencing the microbiome sequencing services market. As healthcare providers seek to tailor treatments based on individual microbiome profiles, the demand for comprehensive sequencing services is expected to rise. This trend is particularly relevant in the development of probiotics and microbiome-based therapies, where understanding the unique microbial composition of patients can lead to more effective interventions. Additionally, the integration of bioinformatics tools and machine learning algorithms is enhancing data analysis capabilities, allowing for deeper insights into microbiome dynamics and their implications for health.

Furthermore, the increasing focus on preventive healthcare and wellness is driving interest in microbiome research. Consumers are becoming more aware of the importance of gut health and its connection to overall well-being, leading to a surge in demand for microbiome testing services. The rise of direct-to-consumer testing kits is also contributing to market growth, as individuals seek to understand their microbiome profiles and make informed lifestyle choices. In summary, the microbiome sequencing services market is set for robust expansion, characterized by technological advancements, a focus on personalized health, and a commitment to enhancing our understanding of the microbiome's role in human health.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Technology

  • Sequencing By Synthesis (SBS)
  • Sequencing By Ligation (SBL)
  • Pyrosequencing
  • Sanger Sequencing
  • Other Technologies

By Laboratory Type

  • Dry labs
  • Wet Labs

By Research Type

  • Outsourced Research
  • Internal Research

By Application

  • Shotgun Sequencing
  • Targeted Gene Sequencing
  • RNA Sequencing
  • Whole Genome Sequencing
  • Other Applications

By End User

  • Research and Academic Institutes
  • Pharmaceutical and Biotechnology Companies
  • Others
  • COMPANIES PROFILED
  • Baseclear B.V.
  • Zymo Research Corporation
  • Second Genome
  • MR DNA (Molecular Research LP)
  • Microbiome Insights
  • Merieux NutriSciences Corporation
  • Clinical-Microbiomics A/S
  • Rancho BioSciences
  • Diversigen
  • Molzym GmbH & Co. KG
  • BioSpherex LLC
  • TGen
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. MICROBIOME SEQUENCING SERVICES INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Technology
    • 3.7.2 Market Attractiveness Analysis By Synthesis (SBS)
    • 3.7.3 Market Attractiveness Analysis By Ligation (SBL)
    • 3.7.4 Market Attractiveness Analysis By Research Type
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET ANALYSIS BY TECHNOLOGY

  • 5.1. Overview By Technology
  • 5.2. Historical and Forecast Data Analysis By Technology
  • 5.3. Sequencing Historic and Forecast Sales By Regions

6. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET ANALYSIS BY SYNTHESIS (SBS)

  • 6.1. Overview By Synthesis (SBS)
  • 6.2. Historical and Forecast Data Analysis By Synthesis (SBS)
  • 6.3. Sequencing Historic and Forecast Sales By Regions

7. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET ANALYSIS BY LIGATION (SBL)

  • 7.1. Overview By Ligation (SBL)
  • 7.2. Historical and Forecast Data Analysis By Ligation (SBL)
  • 7.3. Pyrosequencing Historic and Forecast Sales By Regions
  • 7.4. Sanger Sequencing Historic and Forecast Sales By Regions
  • 7.5. Others Historic and Forecast Sales By Regions
  • 7.6. ByLaboratory Type Historic and Forecast Sales By Regions
  • 7.7. Dry labs Historic and Forecast Sales By Regions
  • 7.8. Wet Labs Historic and Forecast Sales By Regions

8. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET ANALYSIS BY RESEARCH TYPE

  • 8.1. Overview By Research Type
  • 8.2. Historical and Forecast Data Analysis By Research Type
  • 8.3. Outsourced Research Historic and Forecast Sales By Regions
  • 8.4. Internal Research Historic and Forecast Sales By Regions
  • 8.5. ByApplication Historic and Forecast Sales By Regions
  • 8.6. Shotgun Sequencing Historic and Forecast Sales By Regions
  • 8.7. Targeted Gene Sequencing Historic and Forecast Sales By Regions
  • 8.8. RNA Sequencing Historic and Forecast Sales By Regions
  • 8.9. Whole Genome Sequencing Historic and Forecast Sales By Regions
  • 8.10. Other Historic and Forecast Sales By Regions
  • 8.11. ByEnd User Historic and Forecast Sales By Regions
  • 8.12. Research and Academic Institutes Historic and Forecast Sales By Regions
  • 8.13. Pharmaceutical and Biotechnology Companies Historic and Forecast Sales By Regions
  • 8.14. Others Historic and Forecast Sales By Regions

9. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE MICROBIOME SEQUENCING SERVICES COMPANIES

  • 10.1. Microbiome Sequencing Services Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF MICROBIOME SEQUENCING SERVICES INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Baseclear B.V.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Zymo Research Corporation
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Second Genome
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. MR DNA (Molecular Research LP)
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Microbiome Insights
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. MéRieux NutriSciences Corporation
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Clinical-Microbiomics A/S
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Rancho BioSciences
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Diversigen
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Molzym GmbH & Co. KG
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. BioSpherex LLC
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Tgen
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies